National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

palifosfamide
A synthetic mustard compound with potential antineoplastic activity. An active metabolite of ifosfamide covalently linked to the amino acid lysine for stability, palifosfamide irreversibly alkylates and cross-links DNA through GC base pairs, resulting in irreparable 7-atom inter-strand cross-links; inhibition of DNA replication and cell death follow. Unlike ifosfamide, this agent is not metabolized to acrolein or chloroacetaldehyde, metabolites associated with bladder and CNS toxicities. In addition, because palifosfamide does not require activation by aldehyde dehydrogenase, it may overcome the tumor resistance seen with ifosfamide. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:isophosphoramide mustard-lysine
Abbreviation:IPM-lysine
Code name:ZIO-201
Chemical structure names:
  • N,N'-bis(2-chloroethyl)phosphorodiamidic acid
  • phosphorodiamidic acid, N,N'-bis(2-chloroethyl)-



Previous:padeliporfin, PADRE 965.10, PADRE-CMV fusion peptide vaccine, Palestrol, palifermin
Next:Pallace, palladium Pd 103, palladium-bacteriopheophorbide, palonosetron hydrochloride, pamidronate disodium

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov